A recent article in the New England Journal of Medicine raises the issue of whether surgeons who become sleep deprived should notify patients who are having elective surgery so that patients can decide whether to postpone the procedure or request another physician.
The Ohio Department of Insurance released its most recent report – Ohio 2009 Medical Professional Liability Closed Claim Report – which indicated that after four years of decline, malpractice suits are on the rise in the state.
It has been more than a decade since the publication of the Institute of Medicine’s “To Err is Human,” a report highlighting the fact that medical errors cause up to 98,000 deaths and more than one million injuries each year in the United States.
Robot-assisted radical prostatectomy (RARP) is comparable to conventional RP with regard to biochemical recurrence-free survival (BCRFS) in men with high-grade prostate cancer (PCa), study findings suggest.
An investigational calcium-free phosphate binder called colestilan is safe and effective for controlling phosphorus in dialysis patients, and it has no impact on calcium levels, researchers reported.
Cholesterol-lowering treatment with a combination of ezetimibe and simvastatin significantly decreases the likelihood of major atherosclerotic events in patients with chronic kidney disease (CKD), according to the findings of the five-year Study of Heart and Renal Protection (SHARP) trial.
Hypofractionated image-guided radiation could delay use of systemic therapy, which can be quite toxic.
Treatment is associated with low toxicity and excellent long-term outcomes in men with localized PCa.
An investigational technique being tested in humans can visualize the metabolic processes occurring in a prostate tumor in real-time, potentially providing valuable information for “watchful waiting” and other treatment strategies.
Daily aspirin reduced deaths from prostate cancer (PCa) and some other common cancers during and after eight randomized trials comparing the regimen with placebo.
